ABVX: Nilai perusahaan marang bathi resik ABIVAX
Stable demand for IBD therapy promises ABIVAX (ABVX) multi-year excess profits, which is confirmed by the P/E multiple level, where the current status is -15.90. The success of the biopharmaceutical business relies on clinical test results and regulatory approvals. Meanwhile, the operating model is protected by its humanitarian status, minimizing any geopolitical risks and sanctions pressure.
%20Pangali%20P%2FE&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_ABVX_-_ABIVAX_-_PE-Multiple "ABVX: Periode bali modal bisnis Abivax SA 21.02.2024 - 12.11.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan ABIVAX (ABVX)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- informasi babagan utang lan solvabilitas:
- rincian bathi lan kelipatan pasar:
ABVX - Bathi resik|Bathi sing dikarepake ABIVAX|ABVX - Pangali P/E|Kapitalisasi marang proyeksi bathi Abivax S.A.|ABVX - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Abivax SA|ABVX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Abivax|ABVX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan abivax.com|ABVX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep ABIVAX
Analisis komprehensif perusahaan:Abivax SA ABVX
The stability of ABIVAX (ABVX) depends on the successful market launch of obefeximod for the therapy of intestinal inflammation. By analyzing the P/E ratio, an investor determines the premium for future earnings, where an increasing multiple reflects market confidence in the drug's commercialization, while an excessive surge signals an overpayment for the asset and a decrease in potential investment returns.
Pesaing wigati
Pangali P/E argenx.com|Koefisien rega marang bathi BNTX (BioNTech)|ADMA (ADMA Biologics Inc) - Nilai perusahaan marang bathi resik|Pangali P/E PTGX (Protagonist Therapeutics Inc)|Periode bali modal bisnis Immunovant Therapeutics (IMVT)|KNSA - Rasio rega marang bathi|grifols.com (GRFS) - Koefisien rega marang bathi|Adaptive Biotechnologies Corporation (ADPT) - Rasio rega marang bathi|Koefisien rega marang bathi Celldex Therapeutics Inc|Koefisien rega marang bathi AUPH|Pangali P/E BioCryst Corp|Rasio rega marang bathi Vera Therapeutics, Inc. (VERA)|dianthustx.com - Pangali rega marang bathi|Pangali P/E PHVS (Pharvaris)|AbCellera Corp (ABCL) - Kapitalisasi marang bathi|Tourmaline Corp - Pangali P/E|PGEN - Pangali P/E|PHAR: Pangali P/E|NKTR (nektar.com) - Rasio rega marang bathi|UPB (Upstream Bio) - Pangali P/E|Zenas Bio (ZBIO) - Periode bali modal bisnis|Koefisien rega marang bathi IMNM (Immunome Corp)|Rasio rega marang bathi GOSS (Gossamer Bio Corp.)|Pangali P/E KALV (KalVista Pharmaceuticals)|Pangali P/E septerna.com SEPN|PVLA: Koefisien rega marang bathi|SVRA (Savara Inc) - Pangali rega marang bathi|RIGL: Pangali P/E|AnaptysBio Inc. (ANAB) - Pangali P/E|ATXS (Astria Therapeutics) - Pangali P/E|Rasio rega marang bathi ENGN|Koefisien rega marang bathi RAPT (RAPT Therapeutics)|Rasio rega marang bathi JBIO (aerovatetx.com)|Aclaris - Koefisien rega marang bathi|KYTX: Pangali rega marang bathi|TLSA - Rasio rega marang bathi|Kapitalisasi marang bathi resik CABA|VTYX: Pangali P/E|Theratechnologies, Inc. - Nilai perusahaan marang bathi resik|AVTX (Avalo Therapeutics Inc.) - Pangali P/E|Pangali P/E Eledon Pharmaceuticals, Inc|Rasio rega marang bathi Agenus (AGEN)|CLYM (climbbio.com) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Zura Bio ZURA|ATYR - Koefisien rega marang bathi|Adagene Corp - Pangali P/E|IMA - Pangali P/E|STTK (shattucklabs.com) - Koefisien rega marang bathi|Equillium - Nilai perusahaan marang bathi resik|CNTB (Connect Biopharma Holdings) - Pangali P/E|Immunic Inc (IMUX) - Periode bali modal bisnis|Rasio rega marang bathi Atara Biotherapeutics (ATRA)|Koefisien rega marang bathi inflarx.de IFRX|Rasio rega marang bathi X4 Pharmaceuticals XFOR|ACET - Koefisien rega marang bathi|CELU: Koefisien rega marang bathi|INMB - Pangali P/E|Barinthus Bio (BRNS) - Rasio rega marang bathi|Pangali rega marang bathi KZR|SABS (SAB Biotherapeutics) - Pangali P/E|Kapitalisasi marang bathi akaritx.com AKTX|Pangali P/E ENLV|Pangali P/E q32bio.com (QTTB)|Pangali P/E GOVX (GeoVax Labs Inc)|Edesa Biotech Corp - Rasio rega marang bathi|iBio, Inc. - Pangali P/E|Periode bali modal bisnis Carisma Therapeutics CARM|XTLB (XTL Biopharmaceuticals Ltd.) - Koefisien rega marang bathi|BOLT (Bolt Biotherapeutics, Inc.) - Rasio rega marang bathi|HCWB (HCW Biologics, Inc.) - Pangali P/E|Pangali P/E Aptevo|Koefisien rega marang bathi AIM (AIM ImmunoTech Inc.)|aditxt.com - Pangali rega marang bathi|Pangali P/E GRI (GRI Bio)|Pangali P/E XORTX Therapeutics Inc XRTX|ReShape Lifesciences - Pangali P/E|REVB: Rasio rega marang bathi|INDP (Indaptus Therapeutics) - Koefisien rega marang bathi|SCNI (scinai.com) - Rasio rega marang bathi|Koefisien rega marang bathi CALI|Pangali rega marang bathi AFMD (Affimed Therapeutics)|Rasio rega marang bathi Allakos Inc. (ALLK)|HOOK: Kapitalisasi marang bathi resik|Pangali P/E IGMS (IGM Biosciences)|Nilai perusahaan marang bathi resik ITOS|Ocean Biomedical - Pangali P/E|TCBP - Pangali P/E|Third Harmonic Bio, Inc (THRD) - Rasio rega marang bathi
